Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (R/R MM).

被引：34
作者：
Usmani, Saad Zafar
Mateos, Maria-Victoria
Nahi, Hareth
Krishnan, Amrita Y.
van de Donk, Niels W. C. J.
San Miguel, Jesus
Oriol, Albert
Rosinol, Laura
Chari, Ajai
Adams, Homer
Girgis, Suzette
Lin, Shun Xin Wang
Stephenson, Tara
Kemmerer, Kristy
Smit, Jennifer
Elsayed, Yusri A.
Infante, Jeffrey R.
Goldberg, Jenna D.
Banerjee, Arnob
Garfall, Alfred L.
机构：
[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[2] Univ Hosp Salamanca IBSAL, Salamanca, Spain
[3] Karolinska Inst, Stockholm, Sweden
[4] Karolinska Univ Hosp Huddinge, Stockholm, Sweden
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands
[7] Clin Univ Navarra, Pamplona, Spain
[8] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain
[9] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Badalona, Spain
[10] Hosp Clin Barcelona, Barcelona, Spain
[11] Mt Sinai Sch Med, Dept Hematol Oncol, New York, NY USA
[12] Janssen Res & Dev LLC, Spring House, PA USA
[13] Janssen Res & Dev LLC, Raritan, NJ USA
[14] Perelman Sch Med, Philadelphia, PA USA
[15] Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
10.1200/JCO.2020.38.15_suppl.100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
100
引用
收藏
页数：2
相关论文
共 50 条
[21]   Pharmacokinetics and Immunogenicity of Abbv-383, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific T-Cell-Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) [J].
Polepally, Akshanth R. ;
Biesdorf, Carla ;
Uddin, Muhammad Erfan ;
Boehm, Nils ;
Ross, Jeremy A. ;
Kumar, Shaji Kunnathu ;
Voorhees, Peter M. ;
D'Souza, Anita ;
Weisel, Katja ;
Bueno, Orlando ;
Talati, Chetasi ;
Menon, Rajeev M. .
BLOOD, 2023, 142
[22]   A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen x CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma [J].
D'Souza, Anita ;
Shah, Nina ;
Rodriguez, Cesar ;
Voorhees, Peter M. ;
Weisel, Katja ;
Bueno, Orlando F. ;
Pothacamury, Rajvineeth K. ;
Freise, Kevin J. ;
Yue, Susan ;
Ross, Jeremy A. ;
Polepally, Akshanth R. ;
Talati, Chetasi ;
Lee, Shane ;
Jin, Ziyi ;
Buelow, Ben ;
Vij, Ravi ;
Kumar, Shaji .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) :3576-+
[23]   Health-related quality of life in patients with relapsed/refractory multiple myeloma (RRMM) treated with teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody: Patient-reported outcomes in MajesTEC-1. [J].
Martin, Thomas G. ;
Moreau, Philippe ;
Usmani, Saad Zafar ;
Garfall, Alfred L. ;
Mateos, Maria-Victoria ;
San-Miguel, Jesus F. ;
Rocafiguera, Albert Oriol ;
Nooka, Ajay K. ;
Rosinol, Laura ;
Chari, Ajai ;
Karlin, Lionel ;
Krishnan, Amrita Y. ;
Bahlis, Nizar J. ;
Popat, Rakesh ;
Besemer, Britta ;
Martinez, Joaquin ;
Delforge, Michel ;
Fastenau, John ;
Gries, Katharine S. ;
van de Donk, Niels W. C. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[24]   Initial Results of a Phase I Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Relapsed/Refractory Multiple Myeloma [J].
Rodriguez, Cesar ;
D'Souza, Anita ;
Shah, Nina ;
Voorhees, Peter M. ;
Ben Buelow ;
Vij, Ravi ;
Kumar, Shaji K. .
BLOOD, 2020, 136
[25]   Correlative biomarker analyses for optimal therapeutic dose determination of ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM). [J].
Ahsan, Aarif ;
Mantis, Christine ;
Luo, Xizhi ;
Zhang, Catherine C. ;
Valdes, Cesar Rodriguez ;
Voorhees, Peter M. ;
D'Souza, Anita ;
Chung, Alfred ;
Tuchman, Sascha ;
Safah, Hana ;
Mckay, John T. ;
Weisel, Katja C. ;
Teipel, Raphael ;
Korde, Neha ;
Vij, Ravi ;
Kumar, Shaji ;
Bueno, Orlando Felix ;
Pothacamury, Rajvineeth Kumar ;
Talati, Chetasi ;
Ross, Jeremy A. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[26]   POPULATION PHARM ACOKINETICS (POPPK) OF ABBV-383, A B-CELL MATURATION ANTIGEN (BCMA) x CD3 BISPECIFIC T-CELL-REDIRECTING ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) [J].
Polepally, A. ;
Badillo, J. ;
Rinas, M. ;
Ahsan, A. ;
Bueno, O. ;
Talati, C. ;
Menon, R. ;
Engelhardt, B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 :S69-S69
[27]   MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM) [J].
Levy, Moshe ;
Bahlis, Nizar ;
Raje, Noopur ;
Costello, Caitlin ;
Dholaria, Bhagirathbhai ;
Solh, Melhem ;
Tomasson, Michael ;
Dube, Harman ;
Damore, Michael ;
Lon, Hoi Kei ;
Basu, Cynthia ;
Skoura, Athanasia ;
Chan, Edward ;
Trudel, Suzanne ;
Jakubowiak, Andrzej ;
Chu, Michael ;
Gasparetto, Cristina ;
Dalovisio, Andrew ;
Sebag, Michael ;
Lesokhin, Alexander .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S439-S439
[28]   Elranatamab, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, for Patients With Relapsed/ Refractory Multiple Myeloma (RRMM): Extended Follow-Up and Biweekly Administration From the MagnetisMM-3 Study [J].
Mohty, Mohamad ;
Tomasson, Michael H. ;
Arnulf, Bertrand ;
Bahlis, Nizar J. ;
Prince, H. Miles ;
Niesvizky, Ruben ;
Rodriguez-Otero, Paula ;
Martinez-Lopez, Joaquin ;
Koehne, Guenther ;
Jethava, Yogesh ;
Gabayan, Afshin E. ;
Stevens, Don A. ;
Nooka, Ajay K. ;
Raje, Noopur ;
Iida, Shinsuke ;
Leip, Eric ;
Conte, Umberto ;
Czibere, Akos ;
Viqueira, Andrea ;
Lesokhin, Alexander M. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S493-S494
[29]   Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): extended follow up and biweekly administration from the MagnetisMM-3 study [J].
Raab, M. S. ;
Haenel, M. ;
Mohty, M. ;
Tomasson, M. H. ;
Arnulf, B. ;
Bahlis, N. J. ;
Prince, H. M. ;
Niesvizky, R. ;
Rodriguez-Otero, P. ;
Martinez-Lopez, J. ;
Koehne, G. ;
Jethava, Y. ;
Gabayan, A. E. ;
Stevens, D. A. ;
Nooka, A. K. ;
Raje, N. ;
Iida, S. ;
Leip, E. ;
Conte, U. ;
Czibere, A. ;
Viqueira, A. ;
Lesokhin, A. M. .
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :177-178
[30]   Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study. [J].
Mohty, Mohamad ;
Tomasson, Michael H. ;
Arnulf, Bertrand ;
Bahlis, Nizar J. ;
Prince, H. Miles ;
Niesvizky, Ruben ;
Rodriguez-Otero, Paula ;
Martinez-Lopez, Joaquin ;
Koehne, Guenther ;
Jethava, Yogesh ;
Gabayan, A. Eli ;
Stevens, Don A. ;
Nooka, Ajay K. ;
Raje, Noopur S. ;
Iida, Shinsuke ;
Leip, Eric ;
Conte, Umberto ;
Czibere, Akos Gabor ;
Viqueira, Andrea ;
Lesokhin, Alexander M. .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345